We are known for our high-quality and expansive in vivo, in vitro, and ex vivo preclinical models, and partner with our clients to quantify the efficacy and pharmacological profile of their drug candidate(s) before they move into the clinic. We aim to deliver superior drug candidates to ensure that patients get the right treatment at the right time. Schedule a meeting with our team by completing the form.
Sherr AquinoExecutive Director, Business Development, US West |
Alex VilaDirector, Business Development, US West |
Steven FeckleyExecutive Director, Business Development, Clinical Biomarker Assessment |
Sadaf MalikSenior Director, Business Development, US West
|
Dean CampbellSenior Director, Scientific Engagement |
Francesca VenaDirector, Business Development, US East |
Executive Director, Business Development, US West |
|
Director, Business Development, US West |
|
|
Executive Director, Business Development, Clinical Biomarker Assessment |
Senior Director, Business Development, US West
|
|
Senior Director, Scientific Engagement |
|
Director, Business Development, US East |
Your privacy is important to us.
We'll never share your information.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-05-13
2024-04-30
landing_page
BIO 2024